{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009704","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.023670+00:00","generated_at":"2026-05-31T22:33:35.374933+00:00","sec_items":["1.01","3.02","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"ReShape Lifesciences announces reverse merger with Vyome Therapeutics and asset sale for $5.16M","bullets":["Vyome stockholders will own 88.9% of combined company; ReShape stockholders to own 11.1%.","ReShape sells substantially all assets to Ninjour (Biorad Medisys affiliate) for $5.16M cash; Merger closes immediately after.","Series C Preferred liquidation preference reduced from $26.2M to at most $1M or 20% of asset sale price or excess net cash.","Up to $7.3M in concurrent financing includes $5.8M common stock at 30% discount to post-merger valuation.","CEO Paul Hickey receives severance increase to 18 months base salary and 4% fully diluted shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009704","json":"https://secwatch.observer/filing/0001558370-24-009704.json","markdown":"https://secwatch.observer/filing/0001558370-24-009704.md","text":"https://secwatch.observer/filing/0001558370-24-009704.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024009704/0001558370-24-009704-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024009704/rsls-20240708x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T22:33:35.374933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}